uric acid has been researched along with Anaphylaxis in 4 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Anaphylaxis: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
Excerpt | Relevance | Reference |
---|---|---|
"To assess efficacy, safety, pharmacokinetics, and immunogenicity of pegloticase plus methotrexate (MTX) versus pegloticase plus placebo cotreatment for uncontrolled gout in a randomized, placebo-controlled, double-blind trial." | 9.69 | A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings. ( Botson, JK; Chamberlain, J; Grewal, S; La, D; LaMoreaux, B; LoCicero, K; Majjhoo, A; Obermeyer, K; Ong, S; Parikh, N; Peterson, J; Saag, K; Sainati, S; Tesser, JRP; Verma, S; Weinblatt, ME; Xin, Y, 2023) |
"To assess efficacy, safety, pharmacokinetics, and immunogenicity of pegloticase plus methotrexate (MTX) versus pegloticase plus placebo cotreatment for uncontrolled gout in a randomized, placebo-controlled, double-blind trial." | 5.69 | A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings. ( Botson, JK; Chamberlain, J; Grewal, S; La, D; LaMoreaux, B; LoCicero, K; Majjhoo, A; Obermeyer, K; Ong, S; Parikh, N; Peterson, J; Saag, K; Sainati, S; Tesser, JRP; Verma, S; Weinblatt, ME; Xin, Y, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Botson, JK | 1 |
Saag, K | 1 |
Peterson, J | 1 |
Parikh, N | 1 |
Ong, S | 1 |
La, D | 1 |
LoCicero, K | 1 |
Obermeyer, K | 1 |
Xin, Y | 1 |
Chamberlain, J | 1 |
LaMoreaux, B | 1 |
Verma, S | 1 |
Sainati, S | 1 |
Grewal, S | 1 |
Majjhoo, A | 1 |
Tesser, JRP | 1 |
Weinblatt, ME | 1 |
Fuchs, D | 1 |
Hermann, J | 1 |
Zintl, F | 1 |
Plenert, W | 1 |
Maeda, M | 1 |
Tanaka, Y | 1 |
Suzuki, T | 1 |
Nakamura, K | 1 |
Poznansky, MJ | 1 |
1 trial available for uric acid and Anaphylaxis
Article | Year |
---|---|
A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings.
Topics: Adult; Anaphylaxis; Arthritis, Gouty; Double-Blind Method; Gout; Gout Suppressants; Humans; Methotre | 2023 |
3 other studies available for uric acid and Anaphylaxis
Article | Year |
---|---|
[Basic therapy in children with leukemia and a malignant tumors. II].
Topics: Allopurinol; Anaphylaxis; Anemia; Antibiotics, Antineoplastic; Bicarbonates; Blood Transfusion; Chil | 1978 |
[Pharmacological studies on carprofen, a new non-steroidal anti-inflammatory drug, in animals (author's transl)].
Topics: Adrenal Cortex; Analgesics; Anaphylaxis; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents | 1977 |
In vitro and in vivo activity of soluble cross-linked uricase-albumin polymers: a model for enzyme therapy.
Topics: Albumins; Anaphylaxis; Animals; Dogs; Polymers; Solubility; Time Factors; Urate Oxidase; Uric Acid | 1979 |